Concepedia

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Di Jiang, Hao‐Wen Sim, Osvaldo Espin‐Garcia, Bryan Chan, Akina Natori, Charles Henry Lim, Stephanie Moignard, Eric X. Chen, Geoffrey Liu, Gail Darling,

Oncology · 2020 · 14 citations · 15 references

DOIFull text

Open access

Abstract

TMT with CF and CP produced comparable outcomes. However, for dCRT, CF may be a superior regimen.

References

15

A simulation study of the number of events per variable in logistic regression analysis

Peter Peduzzi, John Concato, Elizabeth Kemper et al. · Journal of Clinical Epidemiology · 1996 · 8.5K citations · Full text

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

, , +9

A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma

T. N. Walsh, N. Noonan, Donal Hollywood et al. · New England Journal of Medicine · 1996 · 2K citations · Full text

Chemoradiotherapy of Locally Advanced Esophageal Cancer

Jay S. Cooper, Matthew Guo, Arnold Herskovic et al. · JAMA · 1999 · 1.9K citations

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

Bruce D. Minsky · Journal of Clinical Oncology · 2002 · 1.4K citations